Moreover, in colorectal cancer cells, treatment with the copper ionophore Elesclomol results in reduced ATP7A levels and increased ubiquitination, which impairs copper efflux, promotes mitochondrial copper accumulation, and causes ROS overflow. This evidence concerns the gene ATP7A and colorectal cancer.